Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics

Executive Team

Dan Snyder
President and CEO

Glenn J. Dozier
Acting Chief Financial Officer

Glenn A. Miller, Ph.D.
Executive Vice President
Chief Technology Officer

Chad Galderisi, D.O.
Executive Vice President/Chief Medical Officer
Laboratory Director

MolecularMD discusses the clinical application of liquid biopsy or circulating tumor DNA (ctDNA) and its benefits within the field of oncology and companion diagnostics.